Pancreatic Cancer Research

ResearcherSichuan UniversityNo recent work listed

Ying Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1399-4281; OpenAlex author ID A5101897673. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 3

  1. TRIM16 promotes aerobic glycolysis and pancreatic cancer metastasis by modulating the NIK-SIX1 axis in a ligase-independent manner. First author PMID 36504902↗
  2. Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic signaling pathway. Last author DOI 10.3892/ol.2021.12699↗
  3. A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer. Last author DOI 10.1007/s00280-018-3658-9↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Min Huang · 2 shared papers, 2018–2021 · strength 0.23
  2. Hengqing Zhu · 1 shared paper, 2022 · strength 0.15
  3. Leifeng Chen · 1 shared paper, 2022 · strength 0.15
  4. Yumin Qiu · 1 shared paper, 2022 · strength 0.15
  5. Xiaogang Peng · 1 shared paper, 2022 · strength 0.15
  6. Bin Zhou · 1 shared paper, 2022 · strength 0.15
  7. Xianzhou Huang · 1 shared paper, 2021 · strength 0.14
  8. Yi Cheng · 1 shared paper, 2018 · strength 0.09
  9. Hong Zhu · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.